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Background: To set up an experimental model of cadaveric heart in order to evaluate and compare histologic
transmurality of lesions immediately caused by different energy sources of anti-arrhythmic epicardial devices.
Methods: Procedures were performed on a cadaveric human heart in orthotopic position with an ischemic time of
48 h at 37° and supported through the use of cardiopulmonary bypass. Three anti-arrhythmic epicardial devices
were studied: the bipolar forceps Cardioblate BP (Medtronic) for the radiofrequency, the Epicor Ultracinch LP
Ablation device (St. Jude) for ultrasound and the Cardioblate CryoFlex (Medtronic) device for cryoablation.
Histological features of lesions made at the pulmonary venous confluence assessed the effectiveness of different
energy sources.
Results: Over 45 experimentations performed, only 28 were considered correct and retained for histological
analysis. Three distinct groups were studied according to the type of procedure performed: group 1
(Radiofrequency, n = 12), group 2 (ultrasound, n = 4), group 3 (cryoablation, n = 10) and controls (n = 2). All
analysed samples showed histological changes with a success rates of transmurality of 33% for radiofrequency, 25%
for ultrasound and 90% for cryotherapy (p <0.001). The average length of transmurality, when it was reached and
the proportion of transmurality over the total length of the lesion were respectively 12 ± 6 mm and 37 ± 18% for
group 1, 10 mm and 33% for group 2 and 11.1 ± 1.1 mm and 35 ± 5% for group 3.
Conclusion: Immediate detectable histological transmural lesions after epicardial procedure are discontinuous
whatever the kind of energy source tested in this work and it strongly encourages the repetition of radiofrequency
procedures. Nevertheless, our experimental model seems inadequate to assess ultrasound energy efficacy.
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The Cox-maze procedure has proven to be the most ef-
fective surgical procedure for treating atrial fibrillation
(AF) and its adverse consequences [1,2]. Modifications
of the initial Cox-Maze procedure have led to the "cut-
and-sew" Cox III method. The work of Haissaguerre [3]
demonstrated the effectiveness of radiofrequency abla-
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reproduction in any medium, provided the orprocedure. Thus, Cox III has evolved into Cox IV where
most of the sutures have been replaced by lesions pro-
duced by radiofrequency or other energy sources, in
order to decrease operative time, and reduce the haem-
orrhagic risks associated with atrial sutures [4].
“Mini-Maze” procedures with a success rate at 1 year
of 82% [5], simplified the initial plan of Cox, in case of
paroxysmal AF and allowed the promotion of epicardial
treatment of AF, including beating heart and/or minim-
ally invasive approaches [6,7]. In contrast, permanent AF
appears to be maintained by complex reentry circuits de-
fining a new concept of electrical atrial remodelling [8].
Simple pulmonary vein isolation is not sufficient and theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Schematic of the experimental model.
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manent AF. Three energy sources are commonly used
during Cox-Maze IV procedures: radiofrequency, ultra-
sound and cryoablation gas (Argon). Nevertheless, no
consensus exists about the best energy source capable of
reproducing transmurality and continuity of cut-and-sew
lines [9].
The aim of this experimental work was to evaluate
and compare the histologic transmurality of lesions in-
duced immediately by different energy sources from
three antiarrhythmic epicardic devices.
Methods
This study was made possible by the generosity of 45 in-
dividuals who donated their bodies to science through
CERAN (non-profit association for body donations asso-
ciated with the anatomy laboratory of Nantes). The
donor age ranged between 68 and 82 years (mean = 75.2 ±
2.2 years). 55% (n=25) of subjects were male. The bodies
were used "fresh", 48 hours after death (statutory period
required). There was no cadaveric solution for preserva-
tion of the body.
Materials
Three anti-arrhythmic epicardial devices corresponding
to three different energy sources were evaluated: the
Cardioblate® bipolar device (Surgical Ablation System,
Medtronic, Inc) for radiofrequency, the UltraCinch LP®
Ablation device (Epicor Medical Cardiac Ablation Sys-
tem, Saint Jude) for ultrasound or HIFU (High Intensity
Focused Ultrasound), and the Cardioblate CryoFlex® de-
vice (Argon-powered Cryoablation, Medtronic) for
cryoablation. Each antiarrhythmic device was connected
to its specific console: Cardioblate generator (Surgical
Ablation System Generator, Medtronic), Epicor Cardiac
Ablation System (Ablation Control System (ACS), Saint-
Jude) and Cardioblate CryoFlex console (Surgical Abla-
tion Console, Medtronic). The extracorporeal circulation
circuit, assembled in a closed circuit (Sarns), was con-
nected to a heat exchanger (Jostra Quadrox) and a heat
generator (Stockert), simple back. Myocardial tempera-
ture was monitored by a thermal probe, myocardial nee-
dle temperature probe (Genesee Biomedical).
Experimental model
The objective of this study was to design an experimen-
tal model capable of reproducing an epicardial procedure
for atrial fibrillation treatment, at 37°C on a cadaveric hu-
man heart in the orthotopic position and considered
"fresh" (48 hours of ischemic time). The heart cavities were
maintained filled through the use of cardiopulmonary by-
pass. After sternotomy and opening the pericardium, the
pulmonary veins were ligated and dissected away from the
left atrium. The aorta was dissected and clamped close tothe brachiocephalic arterial trunk. An injection cannula,
positioned in the left atrium, and a cannula located in the
aorta allowed the realization of a closed extracorporeal cir-
culation (Figure 1). The fluid flowing through this closed
circuit consisted of 0.9% saline solution. The outflow in
the circuit was 3 l/min and allowed the flow in the left
cardiac cavities to remain near to physiologic conditions
(Figure 2). A coronary circulation could be even observed.
This circuit was coupled to a thermal generator through
a heat exchange membrane type. The temperature of the
assembly was set at 37°C and the myocardial temperature
was constantly monitored. Antiarrhythmic procedures
were performed when myocardial temperature had
reached 37°C.
Protocol epicardial lesion
The radiofrequency and cryoablation devices took the
form of a clamp and the ultrasonic device a collar. The
procedure for issuing different energies was modeled on
clinical practice. Once the process began, the generator
automatically regulated the transmission time for a the-
oretical transmurality of the lesions. Lesions made with
radiofrequency and cryoablation devices showed only a
single line on the right and left pulmonary vein conflu-
ences. The average time of radiofrequency procedures
was 16 ± 1 sec. For cryoablation, epicardial application
time of the Cardioblate CryoFlex® device was 60 seconds,
as recommended by the former manufacturer. For the
ultrasound system, the size of the collar was chosen
using the meter supplied in the kit, with the aim of de-
termining the collar that best fitted the morphology of
the left atrium. The lesion pattern performed with the
ultrasonic collar was the "box lesion", which isolates the
Figure 2 Aortic clamping and positioning of the cannulas. The
left cavities appear filled unlike the right cavities that are not
involved in experimentation.
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confluence from the rest of the left atrium. Once the de-
vice was in place, the generator controlled a long process
intended to result in the transmurality of the lesion. The
average time of application was 10 ± 0.5 min.
Sampling and histological analyses
The effectiveness of different energy sources was as-
sessed using histologic features of the lesions made with
these antiarrhythmic devices. To compare strictly identi-
cal tissue samples, two lesion samples were systematic-
ally taken from each heart. The first sample extended
from the lower edge of the right inferior pulmonary vein
to the upper edge of the right superior pulmonary vein
at the anterior face of the venous confluence. The sec-
ond sample was between the lower edge of the left infer-
ior pulmonary vein to the upper edge of the left superior
pulmonary vein. Considering that lesions could continue
to evolve in the minutes following their induction, histo-
logical samples were taken four hours after the creation
of lesions. Each lesion sample was associated with a
healthy sample of the same tissue. Lesion samples wereFigure 3 Magnification x400 HPS staining. Left: ghost myocytes with no
nuclei. Right: absence of nuclei, viable myocytes.kept in a solution of formalin 10% for more than
24 hours at 4°C. The inclusion was done in paraffin.
Histologic analysis of slides was performed "blind" after
classical staining (hematoxylin phloxine saffron [HPS])
without knowledge of the type of energy used, by a path-
ologist specializing in cardiovascular tissues at the
thorax Institute of Nantes University Hospital.Criteria for histologic evaluation
Transmurality and continuity of the lesions were evalu-
ated histologically. The tissue damage induced by the
procedure was defined by the existence of one or more
of the following histopathologic aspects (Figure 3):
“ghost” myocytes with an absent nucleus or very pale;
coagulation necrosis of myocytes with more hyper-
chromatic eosinophilic with dense nuclei; "patch", in-
volving viable, isolated, and “ghost” or hyperchromatic
myocytes. The procedure was defined as transmural only
when one or more of these histologic lesions were found
throughout the depth of the atrial tissue. The length of
tissue with acquired transmurality was assessed by the
sum of the transmural lesion areas. The maximum
depth of the lesions was also evaluated for each sample.
Along with this histologic evaluation, macroscopic
esophageal lesions were systematically evaluated after
cardiac explantation.Creating a control group
In order to confirm that observed histological features
on a cadaveric heart were similar to a non-cadaveric
heart, a control group was created with different pattern
lesions on a beating heart. After approval by the ethics
committee of the Nantes University Hospital and patient
consent, lesions controls were performed by radio-
frequency on a beating heart at the base of the left
atrium appendage in a 45 years old patient just before
explantation for cardiac transplantation. These lesions
in vivo were compared with identical lesions done dur-
ing two additional experimental procedures on perfused
cadaveric hearts.nucleus and blurred cytoplasmic boundaries. Middle: hyperchromatic
Figure 4 Percentage of procedures in which transmurality
histological lesions were found according to the type of energy
used (* significantly difference between cryotherapy against
both radiofrequency and ultrasound (p=0.0053); ** no
statistical difference between radiofrequency against both
cryotherapy and ulstrasound (p=0.11)).
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Procedures that failed to result in a sealed circuit were
excluded from the study; these were subjects with aortic
stenosis or with intra-cavity thrombus that do not allow
proper operation of the circuit. The unsuitability of
some atriums to ultrasound clamp sizes resulted in the
cancellation of five manipulations.
Statistical analysis
A non-parametric Kruskal-Wallis test was used. Statis-
tical analysis was performed by MedCalc® software, ver-
sion 9.3.7.0.
Results
Of the 45 procedures, only 28 were considered accurate
and retained for histologic analysis. Three groups were
studied according to the type of energy sources: Group 1
(radiofrequency) consisted of 12 subjects aged between
68 to 82 years (8 men/4 women; mean age 73.6 ±
4 years); Group 2 (ultrasonic) consisted of 4 subjects
aged between 75 to 77 years (2 men/2 women; mean age
76±0.8 years) and Group 3 (cryoablation) consisted of 10
subjects aged between 72 to 80 years (6 men / 4 women;
mean age 75.8 ± 2.8 years). A control group with left
atrial appendage radiofrequency lesions (n=2) was cre-
ated in order to compare these lesions with those
obtained on the heart in vivo. There was no significant
difference in age between groups (p=0.17). The total
length of the histologic samples analyzed by subject and
atrial tissue thickness were similar between groups
(Table 1). All samples analyzed showed histologic changes,
demonstrating the success of the procedure in terms of
energy transfer, but depth of lesions depended on the de-
vices. No difference was observed between the three tech-
niques in terms of histologic types of lesions. All tissue
samples studied showed the same histopathologic type of
myocytes, ghosts or hyperchromatic, portions of patch le-
sions, loose interstitial tissue and/or pericellular edema
(Figure 3).
The percentage of procedures in which transmurality
was found in histologic lesions is shown in Figure 4. In
group 1, immediate histologic transmurality was found
in 33% (n=4) of the procedures with radiofrequency.
Among these four samples with transmurality lesions,Table 1 Average of total lengths of histologic samples











33.7 ± 3.3 mm 33.7 ± 2.5 mm 33.1 ± 3.4 mm
Thickness of
atrial tissue
3.71 ± 1.0 mm 3 ± 0.7 mm 3.1 ± 0.46 mmgaps in the radiofrequency line were always observed and
the average length of lesions with transmurality was 12 ±
6 mm per sample, representing 36.5% of the ablated atrial
tissue length. Among samples with no transmural lesion
(n=8), the mean maximum depth of lesions observed was
0.68 ± 0.3 mm for an average tissue thickness of 3.8±1
mm, representing a depth penetration of 19±11%. In
group 2, only 1 (25%) out of 4 procedures had transmural
lesions with a length of 10 mm representing 33% of the
atrial tissue length. Among the 3 procedures with no
transmural lesion, the mean maximum depth of lesions
was 0.41±0.3 mm for an average thickness of 2.6±0.2 mm,
representing a depth penetration of 14.8±10%.
At last, 90% of samples (n=9) in the group 3 had
transmural lesions, with an average length of transmural
lesions of 11.1±1.1 mm, representing a transmurality
length of 35±5% of the atrial tissue.
The macroscopic analysis of the heart and mediasti-
num found no esophageal necrosis or perforation after
the atrial antiarrhythmic procedure.
To validate this model and histologic analysis of lesions,
a radiofrequency lesion was performed on the basis of the
left atrium in a control patient awaiting heart transplant-
ation and compared with two isolated radiofrequency le-
sions of the left atrium of two experimental subjects.
Histopathologically, the lesions observed on the left
atrium of the control patient were similar to lesions ob-
served in the experimental model, but showed no trans-
mural aspect. The bulk of the lesion areas were made of
patch strips while the two left atrial samples from the ex-
perimental model showed transmural lesions (Table 2).Discussion
Several experimental models on the effectiveness of dif-
ferent histologic energy sources have already been made,
either in animal models or in conditions not comparable
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model has the advantage of reproducing the conditions
of a heart “in charge” at 37°C. There is therefore no pro-
tective cooling effect as suggested by some experimental
work showing that tissue temperatures below 37°C de-
creased the transmurality of the lesions when using hot
energy such as radiofrequency and ultrasound [12].
However, none of the epicardial devices evaluated in our
experimental model causes an immediate and continu-
ous transmural lesion on a whole sample. The histologic
interpretation in acute and early phase certainly under-
estimates the importance of the lesion [13], and the elec-
trophysiologic consequences of scarring induced late
after the procedure. Otherwise, the clinical efficacy of
transmurality was also questioned by some clinical and
experimental studies [12,14-18]. Several hypotheses were
raised: new concepts of electro-anatomic remodeling of
the atria associated with the use of these energy sources;
no justification of transmurality of lesions according to
the endocardial or epicardial site of delivery of energy or
the type of AF (permanent or paroxysmal) [19]? One
could indeed imagine that the electrical isolation of
arrhythmia triggers in the pulmonary veins does not ne-
cessarily justify the transmural lesions in cases of parox-
ysmal AF. The fact remains that it is the lesion induced
by the energy source that will determine progress of the
wave of depolarization through the atrium and thus the
effectiveness of the Maze and the electro-anatomic re-
modeling. This discontinuity of transmurality has already
been demonstrated for microwaves [17] and may partly
explain the occurrence of AF recurrence for other en-
ergy sources.
In addition, transmurality of the lesions significantly
depends on the type of energy used in our model, with
immediate transmurality success rates of 25–30% for
radiofrequency and ultrasound against 90% for cryoabla-
tion (p<0.001).
Cryoablation could be even more efficient since the
new recommended application time has increased from
60 sec to 2 minutes. The success rates of immediate
transmurality are small for both radiofrequency and ultra-
sound, whereas in clinical practice, the studies did not find
any clear superiority of cryoablation compared with other
energies in terms of recurrence of AF [20-22].In fact, the histologic findings of our experimental
model corroborate experimental work that demonstrated
a difference in intensity of the lesions induced by differ-
ent types of energy. Rodriguez et al. showed in an ani-
mal model of atrioventricular node ablation that
cryoablation induced histologic lesions that were more
homogeneous and more intense than those induced by
radiofrequency [23]. However, the initial importance of
histologic lesions does not condition electrophysiologic
long-term success [24,25] and some studies have even
observed poorer outcomes with cryoablation versus
radiofrequency in the long term [24,25]. These results
should be interpreted with caution. They are obtained
thanks to nitrous oxide which induces lesions at −60°C.
Epicardial cryoablation is based on Argon and cooled to
−160°C [19]. The interpretation of our results obtained
with radiofrequency could also call into question the val-
idity and effectiveness of our model. We therefore exam-
ined the transmurality of radiofrequency-induced lesions
of the left atrium on a beating heart (given the impossi-
bility to collect at the pulmonary venous confluence),
just before cardiac explantation. No histologic transmural
lesion could be found in this case while two experimental
procedures controls were allowed to find a transmurality
of lesions at the base of the left atrium. Variability in the
amount of adipose tissue may partly explain these results.
The thickness of adipose tissue could reduce atrial
transmurality of radiofrequency lesions [12].
Finally, even if our results with RF does not match the
animal experimental results (99% of the lesions were
transmural in pig heart [26] and 92% of the lesions were
transmural in ovine heart [16]), they seem to corrobor-
ate the human electrophysiological results of Benussi
[27]. He advises to repeat the procedure 3 times around
the pulmonary veins before getting a block, witness of
transmurality.
On the other hand, the rather unfavourable results
obtained with Epicor, question the validity of our experi-
mental model for the assessment of ultrasound. "Non-
conductive" energy, based on the action of HIFU, causes
molecular agitation, nuclear and cell destruction. It is
designed to operate on a beating heart, not on ischemic
hearts or non-beating heart. The discrepancy between
our results and important animal experimental work
[28] or human histological post-mortem work [29]
seems to invalidate our experimental protocol for the
study of ultrasound.
Effectiveness of epicardial lesions, whatever the type of
energy used, could also explain the results, but a com-
parative study, endocardial vs. epicardial energy delivery,
should be performed to confirm this hypothesis.
Finally, we have noticed no associated mediastinal le-
sions, particularly in the oesophagus. An epicardial pro-
cedure, with the orientation of the energy source to the
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source of energy is directed into the oesophagus), seems
to confirm the benign nature of mediastinal structures.
Conclusion
Despite the apparent superiority of cryoablation over
other energy sources, the immediate histologic trans-
mural lesions obtained in our experimental model
remain generally limited or discontinued after an
epicardial procedure. Our results clearly encourage
the repetition of the radiofrequency procedure to ob-
tain a conduction block. These findings support also
the development of hybrid procedure to complete
discontinued lines. Nevertheless, our model seems
inappropriate to the study of ultrasound.
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